Skip to main content
Log in

Platelets, acute inflammation and inflammatory mediators

  • Symposium 6 Studies on Anti-Inflammatory Substances in Animals
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

The anti-inflammatory activity of aspirin-like drugs could derive, at least in part, by inhibiting synthesis and release of prostaglandins or rabbit aorta-contracting substance from platelets. Indeed, aggregation of platelets and the consequent release of inflammatory mediators has been frequently evoked as a factor in the development of the inflammatory reaction. The participation of platelets in acute inflammation was tested in three types of trauma in rats rendered thrombocytopenic with anti-platelet serum. Oedema in response to carrageenin, anti-platelet serum or passive cutaneous anaphylaxis was no different from the controls in thrombocytopenic rats.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. O'Brien, J. R.,Effect of salicylates on human platelets, Lancet1, 779–783 (1968).

    Article  PubMed  Google Scholar 

  2. O'Brien, J. R.,Effect of anti-inflammatory agents on platelets, LancetII, 894–895 (1968).

    Article  Google Scholar 

  3. Robertson, A. L., and Khairallah, P. A.,Effects of angiotensin II on the permeability of the vascular wall, in:Angiotensin (Eds I. H. Page and F. M. Bumpus; Springer Verlag, 1974), p. 500–510.

  4. Vargaftig, B. B.,Search for common mechanisms underlying the various effects of putative inflammatory mediators, in:The Prostaglandins, Vol. 2 (Ed. P. W. Ramwell; Plenum Press, New York 1974), 205–276.

    Google Scholar 

  5. Redei, A., and Kelemen, E.,Presence of platelets in acute experimental inflammatory oedema inhibited by salicylate or cortisone, in:Inflammation Biochemistry and Drug Interaction (Eds A. Bertelli and J. C. Houck; Excerpta Medica Foundation, Amsterdam 1969), p. 261–265.

    Google Scholar 

  6. Gorog, P., and Kovacs, I. B.,The alteration of platelet behaviour during various conditions and the effect of anti-inflammatory agents on platelet aggregation and thrombus formation, in:Inflammation Biochemistry and Drug Interaction (Eds A. Bertelli and J. C. Houck; Excerpta Medica Foundation, Amsterdam 1969), p. 197–203.

    Google Scholar 

  7. Silver, M. J., Smith, J. B., and Ingerman, C. M.,Blood platelets and the Inflammatory process, Agents and Actions4, 233–240 (1974).

    PubMed  Google Scholar 

  8. Smith, J. B., and Willis, A. L.,Aspirin selectively inhibits prostaglandin production in human platelets, Nature, New Biol.231, 235–237 (1971).

    Google Scholar 

  9. Vargaftig, B. B., and Zirinis, P.,Arachidonic acid-induced platelet aggregation accompanied by release of potential inflammatory mediators distinct from PGE 2 and PGF . Nature New Biol.244, 114–116 (1973).

    PubMed  Google Scholar 

  10. Willis, A. L.,Isolation of a chemical trigger for thrombosis, Prostaglandins5, 1–24 (1974).

    PubMed  Google Scholar 

  11. Hamberg, M., Svensson, J., Wakabayashi, T., and Samuelsson, B.,Isolation and Structure of two prostaglandin endoperoxides that cause platelet aggregation, Proc. Nat. Acad. Sci.71, 345–349 (1974).

    PubMed  Google Scholar 

  12. Ubatuba, F. B., Harvey, E. A., and Ferreira, S. H.,Are platelets important in inflammation? Agents and Actions5, 31–34 (1975).

    PubMed  Google Scholar 

  13. Willis, A. L.,Parallel assay of prostaglandin-like activity in rat inflammatory exudate by means of cascade superfusion, J. Pharm. Pharmac.21, 126–128 (1969).

    Google Scholar 

  14. Di Rosa, M., Giroud, J. P., and Willoughby, D. A.,Studies of the mediators of the acute inflammatory response induced in rats in different sites by carrageenin and turpentine, J. Path.104, 15–29 (1971).

    Article  PubMed  Google Scholar 

  15. Ferreira, S. H., Moncada, S., Parsons, M., and Vane, J. R.,The concomitant release of bradykinin and prostaglandin in the inflammatory response to carrageenin, Br. J. Pharmac.23, 74–81 (1973).

    Google Scholar 

  16. Garcia Leme, J., Hamamura, L., Migliorini, R. H., and Leite, M. P.,Influence of diabetes upon the inflammatory response of the rat. A Pharmacological analysis, Eur. J. Pharmac.23, 74–81 (1973).

    Article  Google Scholar 

  17. Moncada, S., Ferreira, S. H., and Vane, J. R.,Prostaglandins, aspirin-like drugs and the oedema of inflammation, Nature246, 217–219 (1973).

    PubMed  Google Scholar 

  18. Thomas, G., and West, G. B.,Prostaglandins as regulators of bradykinin responses, J. Pharm. Pharmac.25, 747–748 (1973).

    Google Scholar 

  19. Williams, T. J., and Morley, J.,Prostaglandins as potentiators of increased vascular permeability in inflammation, Nature246, 215–217 (1973).

    PubMed  Google Scholar 

  20. Lewis, A. J., Nelson, D. J., and Sugrue, M. S.,Potentiation by prostaglandin E 1 and arachidonic acid of inflammation in the rat's paw induced by various phlogogenic agents, Br. J. Pharmac.50, 468P-469P (1974).

    Google Scholar 

  21. Rothschild, A. M.,Pharmacodynamic properties of cellulose sulphate and related polysaccharides — a group of bradykinin releasing compounds, in.International symposium on vasoactive polypeptides: Bradykinin and related kinins (Eds M. Rocha e Silva and H. Rothschild. São Paulo, edart., 1967), p. 197.

  22. Brune, K., Minder, B., Glatt, M., and Schmid, L.,Dopolymorphonuclear leucocytes function as mediators in acute inflammation? In:Future Trends in Inflammation I (Eds G. P. Velo, D. A. Willoughby and J. P. Giroud; Piccin Medical Books, 1974), p. 289–300.

  23. Oor, T. C. S., Riley, P., and Doe, J. E.,Potentiated reagin response to egg albumin in nippostrongylus braziliensis infected rats; II Time-course of the reagin response, Immunology20, 185–189 (1969).

    Google Scholar 

  24. Goose, J., and Blair, A. M. J. S.,Passive cutaneous anaphylaxis in the rat induced with two homologous reaginlike antibodies and its specific inhibition with disodium cromoglycate, Immunology16, 749–760 (1969).

    PubMed  Google Scholar 

  25. Ferreira, S. H., Moncada, S., and Vane, J. R.,Prostaglandins and the signs and symptoms of inflammation, in:Prostaglandin Synthetase Inhibitors (Eds H. J. Robinson and J. R. Vane; Raven Pres, New York 1974) p. 175–187.

    Google Scholar 

  26. Ferreira, S. H.,Prostaglandins and the immunological trauma, Proceedings of VIII European Rheumatology Congress, in press (1975).

  27. Van Arman, G. G. Begany, A. J., Miller, L. M., and Plesse, H. H.,Details of the inflammation caused by yeast and carrageenin, J. Pharmac. exp. Ther.150, 328–334 (1965).

    Google Scholar 

  28. Elliott, R. H. E., Jr., and Whipple, M. A.,Observations on the interrelationship of capillary, platelet and splenic factors in thrombocytopenic purpura, J. Lab. clin. Med.26, 489–498 (1940).

    Google Scholar 

  29. Ackroyd, J. F.,Allergic purpuras, including purpuras due to foods, drugs and infections, Am. J. Med.14, 605–632 (1953).

    Article  PubMed  Google Scholar 

  30. Margaretten, W., and McKay, D. G.,The requirement for platelets in the active Arthus reaction, Am. J. Path.64, 257–263 (1971).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ferreira, S.H., Ubatuba, F.B. & Vane, J.R. Platelets, acute inflammation and inflammatory mediators. Agents and Actions 6, 313–319 (1976). https://doi.org/10.1007/BF01972248

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01972248

Keywords

Navigation